The present invention relates generally to azatriocyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors.

 
Web www.patentalert.com

< Method of multi-region contrast-enhanced magnetic resonance arteriography

< Methods and products related to pulmonary delivery of polysaccharides

> Fused heteroaryl derivatives and their use as p38 kinase inhibitors

> Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
~ 00620